# Transient vitreous opacity following combined intravitreal injection of pegcetacoplan and faricimab-svoa in patients with neovascular age-related macular degeneration and geographic atrophy

**Authors:** Ying Zhang, Carissa Wei, Jay M. Stewart

PMC · DOI: 10.1016/j.ajoc.2026.102545 · American Journal of Ophthalmology Case Reports · 2026-02-12

## Full-text entities

- **Diseases:** vitreous opacification (MESH:D058442), GA (MESH:D057092), Vitreous opacities (MESH:D003318), age-related macular degeneration (MESH:D008268), neovascular (MESH:D016510), vision loss (MESH:D014786), AMD (MESH:D006009)
- **Chemicals:** brolucizumab (MESH:C000622091), Pegcetacoplan (MESH:C000716074), ranibizumab (MESH:D000069579), BSS (-), bevacizumab (MESH:D000068258), ceftazidime (MESH:D002442), vancomycin (MESH:D014640), faricimab (MESH:C000723200)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12934209/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12934209/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12934209/full.md

---
Source: https://tomesphere.com/paper/PMC12934209